InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: chmcnfunds post# 539

Monday, 07/03/2017 4:47:37 PM

Monday, July 03, 2017 4:47:37 PM

Post# of 1162
This rumor may be true but PFE most likely runs lots of stocks through buyout scenarios. It would not surprise me if an offer is made. there are always rumors about who PFE has in their sights.

I picked up some options as a pure spec play because the way the big shift in oncology has happened and the very good news bmy seems to have despite stumbles on a few tests.

The big concern I would have about a buyout is if BMY would actually want to be bought out. If you research the top money buyouts you will see premiums paid of about 30 or 35 percent. That type of premium doesnt even put bmy at its high last year.

Given the bullish sentiment bmy is starting to get it could hit those highs on its own. A merge would make this Pharma's biggest merger ever. Wouldnt be the first time for PFE.

The safe bet seems to buy the stock because regardless if PFE or another company makes a run at them they seem to be undervalued and have a robust pipeline.

Hopefully someone makes a major breakthrough in oncology, it would be awesome. PFE has shifted so much of its focus to oncology maybe they think there are some very good possibil

PFE last buyout was Medivation, another oncology company. usually a certain time period would elapse to assimilate a previous merge before embarking on a new way one.

So far the volume and post do not reflect anything serious, bmy has only rebounded 25% from what was most likely an oversold PPS.

The whole industry could use a couple big buyouts to get biotechs moving again.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News